glp-1 agonist alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus GLP-1 and Alzheimer's Disease: Research
Description
To connect with experts from Stony Brook Medicines Bariatric and Metabolic Weight Loss Center, visit our website or call (631) 444-2274.
Findings from human islets and an in vivo T2D model suggest that these compounds may have the potential to improve T2D treatment
Category Page Category Page on GLP-1 Compare
Glucagon-like peptide 2
Sathyapalan (Eds.), Natural Products and Human Diseases
